Ignite Creation Date:
2024-05-06 @ 5:19 PM
Last Modification Date:
2024-10-26 @ 2:26 PM
Study NCT ID:
NCT05269667
Status:
TERMINATED
Last Update Posted:
2023-11-08
First Post:
2022-02-15
Brief Title:
A Study In Neuromyelitis Optica Spectrum Disorder NMOSD With Satralizumab As An Intervention
Sponsor:
Hoffmann-La Roche
Organization:
Hoffmann-La Roche
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-02
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-26
Completion Date Type:
ACTUAL
First Submit Date:
2022-02-15
First Submit QC Date:
February 25 2022
Study First Post Date:
2022-03-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-06
Last Update Post Date:
2023-11-08
Last Update Post Date Type:
ACTUAL